145 filings
Page 2 of 8
8-K
bl1iij
23 May 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
y81vdcb
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
ARS
5ne bqjwnixj
7 Apr 23
Annual report to shareholders
4:12pm
DEFA14A
7fc8xh nw7m6e2
7 Apr 23
Additional proxy soliciting materials
4:09pm
8-K
lpshsenvdls 6m
10 Mar 23
Regulation FD Disclosure
9:45pm
8-K
tjxa883ui r3wfxd2
8 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
S-8
h0ptf97x7jvh3dvbi2
28 Feb 23
Registration of securities for employees
4:34pm
8-K
dlx3rj9wer2oz
23 Feb 23
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
483gnxw4e861mp8s22h
22 Feb 23
Other Events
8:41am
8-K
u5ctgi
16 Feb 23
Departure of Directors or Certain Officers
8:36am
8-K
je6q xgy9i
13 Feb 23
Entry into a Material Definitive Agreement
4:31pm
8-K
jlqt57 gi4a
25 Jan 23
Departure of Directors or Certain Officers
8:33am
8-K
c1trb3xssa iov
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
saqv6gkkgej1wb79olr
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am
8-K
7sbwru4tay3y5ae
9 Aug 22
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
12:00am